ClinicalTrials.Veeva

Menu

Prevention With Oleanolic Acid of Insulin Resistance (PREOLIA)

U

University of Granada (UGR)

Status

Completed

Conditions

Insulin Resistance
Metabolic Syndrome

Treatments

Other: Olive oil
Other: Functional olive oil

Study type

Interventional

Funder types

Other

Identifiers

NCT05049304
B-AGR-287-UGR18

Details and patient eligibility

About

Oleanolic acid (OA), a triterpene that is highly present in olive leaves, has been proposed as component of functional foods in the prevention of metabolic syndrome due to its anti-inflammatory activity. In this research project we will study the presence of OA in postprandial TRL in healthy adolescents and in normal weight. Moreover, THP-1 macrophages will be incubated with LPS for 48h after pretreatment with OA at different concentrations. Also, TRL will be isolated from healthy adolescents before and 2 and 5h postprandially after the intake of a meal containing the functional olive oil or common olive oil and incubated with THP-1 macrophages.

Enrollment

22 patients

Sex

All

Ages

16 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

-Participants without digestive, metabolic or oncologic disorders or any other pathology

Exclusion criteria

-Not having the informed consent signed by the parents

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

22 participants in 2 patient groups

OA-enriched functional olive oil
Experimental group
Treatment:
Other: Functional olive oil
Olive oil not enriched in OA
Active Comparator group
Treatment:
Other: Olive oil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems